ANI Plans To Shutter Oakville Plant By Q1 2023

Action Part Of Ongoing Efforts To Consolidate Manufacturing Network

 
• By Chloe Kent
  
ANI Pharmaceuticals Canada head office in Oakville
ANI is now seeking to sell its Oakville facility • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business